There’s a fierce debate brewing on Capitol Hill over two competing bills that seek to overhaul our nation’s mental health system. Rep. Ron Barber (D-AZ), a survivor of Jared Loughner’s 2011 mass shooting, has proposed the Strengthening Mental Health in Our Communities Act of 2014, a bill that would provide additional funding for the Substance Abuse and Mental Health Administration (SAMHSA). Barber’s legislation specifically targets at-risk populations who may be underserved − young people, seniors, veterans, and Native American communities − and seeks to provide patient-driven treatment before the illness becomes unmanageable.
In a MIA survey of people who had been patients in mental hospitals, nearly 500 respondents told of an experience that was often traumatic, and frequently characterized by a violation of their legal rights, forced treatment with drugs, and physical or sexual abuse. Only 17% said they were “satisfied” with the “quality of the psychiatric treatment” they received.
The Resilience Investment, Support, and Expansion (RISE) From Trauma Act, legislation designed to increase support for children who have been exposed to Adverse Childhood Experiences, includes $50 million in funding for a “mental health in schools” program. Exactly what these programs would entail remains unclear.
Part two of a Mad In America investigation into the expansion of psychological screening and electronic surveillance of children and youth. Experts point to mounting evidence that scientifically dubious mental health screening programs are just one part of an international governance shift towards creating all-pervasive surveillance systems for diagnosing 'pre-crime' and managing 'at-risk' children and youth. And not only is this not helping kids, critics argue, it’s demonstrably harming them.
In Israel, there is a budding Soteria movement that foretells of a possible paradigm shift in care. The thought is that such care may become a first-line treatment for newly psychotic patients.
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.
When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.
In the past five years, there has been a dramatic explosion of interest in the Open Dialogue Therapy practiced in Tornio, Finland. It is a humanistic “treatment” that has produced five-year outcomes for psychotic patients that are, by far, the best in the developed world, and there are now groups in the United States, Europe and beyond that are seeking to “import” this care. However, the challenges for doing so are many and, last month, Open Dialogue UK - on the occasion of the first-ever fully recognized Open Dialogue training outside of Tornio - organized a conference in London to hold an open dialogue about Open Dialogue.
The International Society for Ethical Psychology and Psychiatry had the clout to draw a stellar line-up of presenters to its recent conference, including internationally prominent critics like David Healy, Peter Gøtzsche, Robert Whitaker and Allen Frances. There were lots of learnings and even some tense discussions, but one of the most intriguing aspects of the entire conference was the way in which scientific and social issues became deeply intertwined, especially when presenters reached for better pathways forward.
Author William Styron is often remembered for speaking about depression as an illness. But a review of his life reveals that psychiatric drugs may have triggered and even worsened his depressive episodes.
Listen: NPR’s On the Media talks about how bad health information ripples through the news. Gary Schwitzer of HealthNewsReview.org cautions against other problematic health reporting in a Breaking News Consumer's Handbook: Health News Edition.
The Mad Pride movement continues to spread around the world, with a first-ever march in Mexico City.
Journalists have called Marianne Williams’ comments on depression dangerous and irresponsible. A closer look reveals that her “opinions” on mental health treatment are more in line with the science, and that the know-it-all assertions by Cooper and colleagues are belied by it.
The New Yorker's story on Laura Delano and psychiatric drug withdrawal is a glass-half-full story: It addresses a problem in psychiatry and yet hides the deeper story to be told. A story of how her recovery resulted from seeing herself within a counter-narrative that tells of the harm that psychiatry can do.
Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Tourette’s. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.
MIA’s Ayurdhi Dhar interviews Diana Kopua about the Mahi a Atua approach, the global mental health movement, and the importance of language and narratives in how we understand our world and ease our suffering.
MIA’s Justin Karter interviews critical psychiatrist and philosopher Pat Bracken about the necessity of challenging received wisdom.
MIA's Peter Simons interviews David Cohen, PhD, on his path to researching mental health, coercive practices, and discontinuation from psychiatric drugs.
In this second part of MIA’s report on compulsory outpatient treatment orders, Michael Simonson tells of how he came to report on this topic, the results from MIA’s survey of people who have experienced such forced treatment, his interviews with several of the survey respondents, and more on Andrew Rich’s life.
Part one of a two-part Mad In America investigation into the expansion of psychological screening and electronic surveillance of children and youth. A new government-funded mental health training program for British Columbia family physicians and school staff promotes screening for mental disorders in all children and youth. Critics say the program omits key scientific evidence, seems more like drug promotion than medical education, and downplays serious potential harms. Nevertheless, programs like it are rolling out across Canada and the US.
Through years of turmoil and confusion, Cindi Fisher’s enduring love for her involuntarily committed son gradually changed her from compliant mom to mental health civil rights activist. That’s when authorities banned her from even contacting her son. But could she be a bellwether of a coming nation-wide wave of protestors?
Dr. Raskin discusses psychotherapists’ dissatisfaction with current psychiatric diagnostic systems and explores alternatives.
The proponents of compulsory outpatient treatment claim that it leads to better outcomes for the recipients, and protects society from violent acts by the "seriously mentally ill." Those claims are belied by history, science, and a critical review of the relevant research.
This review of the scientific literature, stretching across six decades, makes the case that antipsychotics, over the long-term, do more harm than good. The drugs lower recovery rates and worsen functional outcomes over longer periods of time.
Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.
12Page 1 of 2